Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours
- 1 February 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (3) , 364-367
- https://doi.org/10.1016/s0959-8049(97)10065-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Recombinant erythropoietin in acute chemotherapy-induced anemia of children with cancerMedical and Pediatric Oncology, 1995
- Transfusion requirements, risks, and costs for patients with malignancyTransfusion, 1995
- Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.Journal of Clinical Oncology, 1994
- Erythropoietin for anaemia in cancer patientsEuropean Journal Of Cancer, 1993
- Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumorsAnnals of Oncology, 1993
- Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated AnemiaJNCI Journal of the National Cancer Institute, 1992
- Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration.Journal of Clinical Oncology, 1990
- Transfusion-Induced Alloimmunization and Immunosuppression and the Effects of Leukocyte DepletionTransfusion Medicine Reviews, 1989
- Interacting cytokines regulate in vitro human megakaryocytopoiesisBlood, 1989
- Therapy of Renal Anemia with Recombinant Human Erythropoietin in Children with End-Stage Renal DiseasePublished by S. Karger AG ,1988